Table 4. Metabolites detected only in colorectal tumor.
T, colorectal tumor; L, left-sided colon; R, right-sided colon.
| Compound | Frequency (n = 17) | KEGG ID | LMP ID | Description |
|---|---|---|---|---|
| FAD / Flavin adenine dinucleotide | 1 | C00016 | - | Metabolic pathways, Biosynthesis of secondary metabolites; Vitamin digestion and absorption, Riboflavin metabolism |
| PE(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 1 | C00350 | - | Metabolic pathways, Biosynthesis of secondary metabolites; Glycosylphosphatidylinositol (GPI)-anchor biosynthesis, Autophagy, Glycerophospholipid metabolism, Pathogenic Escherichia coli infection, Retrograde endocannabinoid signaling, Kaposi’s sarcoma-associated herpesvirus infection |
| Presqualene diphosphate | 1 | C03428 | LMPR0106010003 | Biosynthesis of antibiotics, Metabolic pathways, Biosynthesis of secondary metabolites; Sesquiterpenoid and triterpenoid biosynthesis, Carotenoid biosynthesis, Steroid biosynthesis |
| 6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''2b'' aglycone | 1 | C11953 | - | Biosynthesis of 12-, 14- and 16-membered macrolides |
| Avermectin A1b monosaccharide | 1 | C11966 | - | Biosynthesis of antibiotics, Biosynthesis of 12-, 14- and 16-membered macrolides |
| 5-O-beta-D-Mycaminosyltylonolide | 1 | C12002 | - | Biosynthesis of antibiotics, Biosynthesis of 12-, 14- and 16-membered macrolides |
| Tetracenomycin B3 | 1 | C12369 | - | Biosynthesis of antibiotics, Biosynthesis of type II polyketide products |
| Stealthin C | 2 | C12392 | - | Biosynthesis of antibiotics, Biosynthesis of type II polyketide products |
| antioside | 2 | C08848 | LMST01120016 | Terpenoids/Steroids |
| Sarsaparilloside | 2 | C08911 | - | Terpenoids/Steroids |
| Glaucarubin | 2 | C08760 | - | Terpenoids/Triterpenoids (C30) |
| Amphotericin B | 3 | C06573 | LMPK06000002 | Type I polyketide structures |
| Cinnamyl benzoate | 5 | - | - | - |
| Verapamil | 2 | C07188 | - | - |
| Enalkiren | 2 | C07466 | - | - |
| Xamoterol | 4 | C11775 | - | - |